In a patient with a hemoglobin of 15 g/dL and a high‑sensitivity C‑reactive protein (hsCRP) of 0.4 mg/L, what is the appropriate work‑up and management for the low white‑cell count?

Work-up and Management for Low White Cell Count

In a patient with hemoglobin 15 g/dL and hsCRP 0.4 mg/L, the low white cell count requires a complete blood count with differential, reticulocyte count, and peripheral blood smear as the initial work-up, followed by assessment for medication effects, autoimmune conditions, and nutritional deficiencies.

Initial Laboratory Assessment

The first step is obtaining a complete blood count (CBC) with differential to characterize the leukopenia and assess other cell lines 1. This is critical because:

• Abnormalities in two or more cell lines warrant hematology consultation 1
• The differential will reveal which white cell lineage is affected (neutropenia, lymphopenia, etc.)
• A reticulocyte count assesses bone marrow response appropriateness 1

Your patient's hemoglobin of 15 g/dL is normal, and the hsCRP of 0.4 mg/L falls in the low cardiovascular risk category (<1.0 mg/L) 2, indicating minimal systemic inflammation. This low inflammatory state makes acute infection, sepsis, or active inflammatory conditions unlikely 3.

Clinical Context Matters

The absence of inflammation (hsCRP 0.4 mg/L) is reassuring and argues against:

• Active infection or sepsis (where CRP rises earlier and more consistently than WBC) 3
• Acute inflammatory conditions
• Bone marrow suppression from systemic illness

This normal hsCRP should be interpreted using the CDC/AHA cutpoints: <1.0 mg/L = low risk, 1.0-3.0 mg/L = average risk, >3.0 mg/L = high risk 2.

Systematic Work-up Algorithm

Step 1: Confirm and Characterize

• Repeat CBC to exclude laboratory error
• Review medication list for:
  • Chemotherapy agents
  • Immunosuppressants
  • Antibiotics (especially beta-lactams)
  • Antithyroid drugs
  • Anticonvulsants

Step 2: Assess for Secondary Causes

• Autoimmune screening: ANA, rheumatoid factor if clinically indicated
• Nutritional deficiencies: Vitamin B12, folate (though these typically cause macrocytic anemia, which your patient doesn't have) 1
• Viral serologies: HIV, hepatitis, EBV, CMV if risk factors present
• Thyroid function: TSH

Step 3: Bone Marrow Evaluation

Consider if:

• Persistent unexplained leukopenia
• Multiple cell lines affected
• Abnormal peripheral smear findings
• No identifiable secondary cause

Common Pitfalls to Avoid

1. Don't rely solely on population reference ranges - Serial trends and baseline values matter more than single measurements 3

2. Don't assume inflammation based on WBC alone - Your patient's low hsCRP demonstrates that WBC and inflammatory markers don't always correlate 4, 5

3. Don't overlook medication effects - This is the most common reversible cause of isolated leukopenia

4. Don't delay hematology referral if pancytopenia is present or if the cause remains unclear after initial work-up 1

Management Approach

• If mild isolated leukopenia (WBC 3.0-4.0 × 10⁹/L): Monitor with repeat CBC in 2-4 weeks
• If moderate leukopenia (WBC 2.0-3.0 × 10⁹/L): Expedite work-up and consider hematology consultation
• If severe leukopenia (WBC <2.0 × 10⁹/L): Urgent hematology referral

The normal hemoglobin and low hsCRP suggest this is likely an isolated hematologic issue rather than a systemic inflammatory or infectious process, which narrows your differential and guides a more focused evaluation.